Copeland Capital Management, LLC - Novozymes A/S ownership

Novozymes A/S's ticker is NVZMY and the CUSIP is 670108109. A total of 19 filers reported holding Novozymes A/S in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Copeland Capital Management, LLC ownership history of Novozymes A/S
ValueSharesWeighting
Q4 2020$2,0000.0%350.0%0.00%
Q3 2020$2,0000.0%350.0%0.00%
Q2 2020$2,0000.0%350.0%0.00%
Q1 2020$2,0000.0%350.0%0.00%
Q4 2019$2,000
+100.0%
350.0%0.00%
Q3 2019$1,000
-50.0%
350.0%0.00%
Q2 2019$2,000350.00%
Other shareholders
Novozymes A/S shareholders Q3 2019
NameSharesValueWeighting ↓
Lenox Wealth Management, Inc. 70,039$3,834,0001.14%
GARRISON BRADFORD & ASSOCIATES INC 15,100$827,0000.67%
Moloney Securities Asset Management, LLC 31,722$1,742,0000.60%
ZEVIN ASSET MANAGEMENT LLC 34,729$1,901,0000.56%
HIGH POINTE CAPITAL MANAGEMENT LLC 6,490$356,0000.48%
BOSTON FINANCIAL MANGEMENT LLC 102,687$5,621,0000.33%
Boston Common Asset Management, LLC 18,656$1,025,0000.13%
Hemenway Trust Co LLC 12,000$657,0000.11%
QUADRANT CAPITAL GROUP LLC 2,011$104,0000.03%
PARAMETRIC PORTFOLIO ASSOCIATES LLC 261,819$14,332,0000.01%
View complete list of Novozymes A/S shareholders